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Datasets provided in this article represent the Rattus norvegicus
primer design and veriﬁcation used in Pink1 / and wildtype
Long Evans brain tissue. Accessible tables include relevant infor-
mation, accession numbers, sequences, temperatures and product
length, describing primer design speciﬁc to the transcript ampli-
ﬁcation use. Additionally, results of Sanger sequencing of qPCR
reaction products (FASTA aligned sequences) are presented for
genes of interest. Results and further interpretation and discussion
can be found in the original research article “Atp13a2 expression in
the periaqueductal gray is decreased in the Pink1 / rat model
of Parkinson disease” [1].
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ow data was
acquiredNational Center for Biotechnology Information (NCBI) Primer Blast was used
to design primers and Sanger sequencing was used for primer conﬁrmation.ata format Raw
xperimental
factorsNetprimers (PREMIER Biosoft, Palo Alto, CA, USA) was used to examine
secondary structure of all primers designed through NCBI Primer Blast to
avoid primer products. Non-template controls were run with each primer
pair to check for formation of primer-dimers and non-speciﬁc ampliﬁcation
products.xperimental
featuresSpeciﬁcity for each primer pair was conﬁrmed using melt curve analysis; all
primer runs yielded single peak melt curves indicating ampliﬁcation of
single gene products. Furthermore, the qPCR reaction product for each gene
was sequenced using Sanger sequencing with both forward and reverse
primers at the University of Wisconsin Biotechnology Center to conﬁrm that
sequences match intended targets.ata source
locationMadison, Wisconsin, USAata accessibility Data are within this articleDValue of the data Data presented here allows for experimental replication.
 Data can be used as a benchmark for other researchers using rat brain tissue.
 Primers can then be manufactured and used in alternative models of Parkinson disease and
then compared to this data set.1. Data
Table 1 describes the rat (Rattus norvegicus) primer information including gene name, gene
abbreviation, GenBanks accession numbers, experimental primer sequences, melt temperature and
product length (base pairs) for each gene (Pink1, Asyn, Th, D1, D2, Atp13a2, Gba, Cﬂar, Gabrb2, Gad1,
Gad2) as well as reference genes (Gapdh, βactin).
Table 2 describes the results of Sanger sequencing of qPCR reaction product for each ampliﬁcation
product from the University of Wisconsin Biotechnology Center. Conﬁrmed results presented are
FASTA sequences conﬁrmed through NCBI Nucleotide BLAST software.2. Experimental design, materials and methods
Netprimer (PREMIER Biosoft, Palo Alto, CA, USA) was used to examine secondary structure of all
primers designed through NCBI Primer Blast to avoid primer products (Table 1). The Pink1 gene
primer was used based on a previous publication [2]. Non-template controls were run with each
primer pair to check for formation of primer-dimers and non-speciﬁc ampliﬁcation products. Spe-
ciﬁcity for each primer pair was conﬁrmed using melt curve analysis; all primer runs yielded single
peak melt curves indicating ampliﬁcation of single gene products. Furthermore, the qPCR reaction
product for each gene was sequenced using Sanger sequencing with both forward and reverse pri-
mers at the University of Wisconsin Biotechnology Center (Table 2). FASTA sequences were entered
into the NCBI Nucleotide BLAST software to conﬁrm that sequences matched intended targets.
Table 1
Rattus norvegicus primer information.
Gene Gene abbre-
viation
Accession
number
Direction Sequences T
(°C)
Product
(bp)
Gapdh glyceraldehyde-3-
phosphate
dehydrogenase
Gapdh NM_017008.4 Forward GGATACTGAGAGCAAGAGAGA 59 106
Reverse TTATGGGGTCTGGGATGGAA
Actb actin, beta βactin NM_031144.3 Forward TGTGGATTGGTGGCTCTATC 59 149
Reverse AGAAAGGGTGTAAAACGCAG
Pink1 PTEN induced puta-
tive kinase 1
Pink1 Primers created
from Dave et al.
[2]
Forward CATGGCTTTGGATGGAGAGT 58 n/a
Reverse TGGGAGTTTGCTCTTCAAGG
Snca synuclein, alpha (non-
A4 component of amy-
loid precursor)
Asyn NM_019169.2 Forward TCAGCCCAGAGCCTTTCAC 58 165
Reverse AGCCACAACTCCCTCCTTG
Th tyrosine hydroxylase Th NM_012740.3 Forward CTTTGACCCAGACACAGCA 59 123
Reverse TGGATACGAGAGGCATAGTTC
Drd1 dopamine receptor
D1
D1 NM_012546.2 Forward GCTGGCTCCCTTTCTTCATC 60 111
Reverse CACCCAAACCACACAAACAC
Drd2 dopamine receptor
D2
D2 NM_012547.1 Forward TCCTTGACCTTCCTCTTGGG 60 188
Reverse CCTGACACTGATGTTGCCTG
Atp13a2 ATPase type 13A2 Atp13a2 NM_001173432.1 Forward CTTCTCTCTGTCTGGCTTCC 60 95
Reverse TCCTCAGTCCGTTGGTGTAG
Gba glucosidase, beta, acid Gba NM_001127639.1 Forward GAGCAGAGTGTTCGGTTAGG 60 115
Reverse GATTCAGGGCAAGGTTCCAG
Cﬂar CASP8 and FADD-like
apoptosis regulator
Cﬂar NM_001033864.2 Forward GTGCTGCTGATGGAGATTGG 60 107
Reverse CTCTTGTCCTTGGCTACCTTG
Gabrb2 gamma-aminobu-
tyric acid (GABA) A
receptor, beta 2
Gabrb2 NM_012957.2 Forward GGTGCTTTGTCTTTGTCTTTATGG 61 130
Reverse CGCATCTTCTCGTTGTTGG
Gad1 glutamate decarbox-
ylase 1
Gad1 NM_017007.1 Forward GACACTTGAACAGTAGAGACCC 61 116
Reverse TGTAGGACGCAGGTTGGTAG
Gad2 glutamate decarbox-
ylase 2
Gad2 NM_012563.1 Forward CCAGGCTCATCGCATTCAC 61 190
Reverse GCACTCACCAGGAAAGGAAC
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Table 2
Results of Sanger sequencing of qPCR reaction product.
Gene FASTA (Aligned Sequence)
Gapdh ATCCCAACTCGGCCCCCAACACTGAGCATCTCCCTCACAATTTCCATCCCAGACCCCCATAA
βactin AGATGTGGATCAGCAAGCAGGAGTACGATGAGTCCGGCCCCTCCATCGTGCACCGCAAATGCTTCTAGGCGGACTGTTAC
PINK1 CTCTTCTCATTTTTCCCGACCAC
Asyn GGGGAAAACAGGAGGAATCAGAGTTCTGCGGAAGCCTAGAGAGCCGTGTGGAGCAAAGATACATCTTTAGCCATGGATGT
Th CCAGCCTGTGTACTTTGTGTCCGAGAGCTTCAATGACGCCAAGGACAAGCTCAGG
D1 GGCTCCCTTTCTTCATCTCGAACTGTATGGTGCCCTTCTGTGGCTCTGAGGAGACCCAGCCAT
D2 TTCCTTGACCTTCCTCTTGGGCACAGAAACTAGCTCAGTGGTCGAGCACACCCTGATCGCTGG
Atp13a2 CGGTGTCTAAGGGGGCACCCTTCCGCCAGCCGCTCTACACCAACGGACTGAGGAA
Gba GCAACTGTTACCACGTCAATTCCATG
Cﬂar CTGATGGAGATTGGGGAGAATTTGAATCAATCTGATGTATCCTCCTTAATTT
Gabrb2 TCTTCTTTGGGAGAGGACCCCAGCGCCAAAAGAAAGCAGCTGAGAAAGCTGCTAATGCCAACAACGAGAAGATGCG
Gad1 GCATCTTCCACGCCTTCGCCTGCAACCTCCTCGAACGCGGGAGCGGATCCTAATACTACCAACCTGCGTCCTACAA
Gad2 GCCTTGGGGATCGGAACAGACAGCGTGATTCTGATTAAATGTGATGAGAGAGGGAAAATGATCCCATCTGACCTTGAAAG
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